Condition
Corticobasal Syndrome (CBS)
Total Trials
7
Recruiting
2
Active
3
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 2 (1)
Trial Status
Completed3
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT07569367Not Yet Recruiting
A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum
NCT05983588Phase 2Active Not RecruitingPrimary
PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)
NCT06647641Recruiting
The CurePSP Genetics Program
NCT07000851Recruiting
Imaging Studies in Corticobasal Syndrome
NCT02966145Completed
4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2
NCT02365922Completed
Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
NCT02133846Phase 1Completed
Safety Study of TPI-287 to Treat CBS and PSP
Showing all 7 trials